ALAS1 antibody (N-Term)
Quick Overview for ALAS1 antibody (N-Term) (ABIN631001)
Target
See all ALAS1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- ALAS1 antibody was raised against the N terminal of ALAS1
-
Purification
- Affinity purified
-
Immunogen
- ALAS1 antibody was raised using the N terminal of ALAS1 corresponding to a region with amino acids ETSAGPSVVSVKTDGGDPSGLLKNFQDIMQKQRPERVSHLLQDNLPKSVS
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
ALAS1 Blocking Peptide, (ABIN938155), is also available for use as a blocking control in assays to test for specificity of this ALAS1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALAS1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ALAS1 (Aminolevulinate, delta-, Synthase 1 (ALAS1))
-
Alternative Name
- ALAS1
-
Background
- Delta-aminolevulinate synthase (ALAS, EC 2.3.1.37) catalyzes the condensation of glycine with succinyl-CoA to form delta-aminolevulinic acid. This nuclear-encoded mitochondrial enzyme is the first and rate-limiting enzyme in the mammalian heme biosynthetic pathway. There are 2 tissue-specific isozymes: a housekeeping enzyme encoded by the ALAS1 gene and an erythroid tissue-specific enzyme encoded by ALAS2.
-
Molecular Weight
- 70 kDa (MW of target protein)
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-